Results 111 to 120 of about 119,179,614 (214)

Clinical approach to the differential diagnosis between immune-mediated diabetes and type 2 diabetes in adult patients

open access: yesFamily Medicine & Primary Care Review, 2023
Barbara Biniek   +4 more
doaj   +1 more source

Neurodegenerative Diseases: Epidemiology, Risk Factors, Classification, Pathophysiology, Clinical Features, Diagnosis, and Therapeutic Strategies

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Neurodegenerative diseases share convergent risk architectures and pathological mechanisms, yet diverge in selective vulnerability, clinical presentation, and therapeutic responsiveness. This review integrates cross‐disease epidemiology, pathophysiology, diagnosis, and treatment, highlighting the transition from symptomatic care toward biomarker‐guided
Zimeng He   +4 more
wiley   +1 more source

Adipose‐Derived Mesenchymal Stem Cells: Isolation, Origin, Phenotype Applications, and Challenges

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Bridging basic biology to clinical translation, this review systematically explores the in vivo origins and evolving isolation techniques of AD‐MSCs. We dissect their diverse phenotype applications orchestrated by immunometabolic reprogramming, mitochondrial transfer, and extracellular vesicles.
Ziyang Liu   +7 more
wiley   +1 more source

Latent Autoimmune Diabetes of Adults Due to Positive Zinc Transporter 8 Antibody

open access: yesAnnals of Internal Medicine: Clinical Cases
This case series reports 3 patients who were diagnosed with type 2 diabetes mellitus (T2DM), treated with oral antidiabetic medications, referred to our endocrinology clinic due to poor glycemic control, and were diagnosed with latent autoimmune diabetes
Jacob Maniattu   +3 more
doaj   +1 more source

Evaluation of a secondary care multidisciplinary clinic for adults with early‐onset type 2 diabetes at high risk in Leicester, Leicestershire and Rutland

open access: yesDiabetic Medicine, Volume 43, Issue 11, November 2026.
Abstract Background Clinical services for adults with early‐onset type 2 diabetes (EOT2D) are in urgent need of improvement. Methods We evaluated a multi‐disciplinary clinic for individuals with EOT2D at high risk (HbA1c >9%/triglyceride >20 mmol/L), providing 2–3 flexibly arranged consultations per individual between March 2024 and September 2025 ...
Jonathan Goldney   +14 more
wiley   +1 more source

Association of BCAAs/BCKAs with pancreatic steatosis in patients with type 2 diabetes mellitus: A cross‐sectional study

open access: yesJournal of Diabetes Investigation, Volume 17, Issue 11, Page 1888-1897, November 2026.
ABSTRACT Aims To examine the association between branched‐chain α‐keto acids (BCKAs) and pancreatic steatosis in patients with type 2 diabetes (T2DM). Methods This cross‐sectional study was conducted from January 2023 to March 2025. Upper abdominal computerized tomography was performed, pancreatic volume (PV), PV index (PVI), CT attenuation of pancreas
Jie Gao   +9 more
wiley   +1 more source

Serum‐derived microribonucleic acids as potential novel biomarkers for slowly progressive type 1 diabetes mellitus

open access: yesJournal of Diabetes Investigation, Volume 17, Issue 11, Page 1876-1887, November 2026.
This study evaluated serum miRNAs as biomarkers in adult patients with SPIDDM. Serum miRNAs were measured at the time of SPIDDM (probable) diagnosis, and miR‐150‐5p was inversely associated with CPI at the last outpatient visit, suggesting its potential utility for predicting subsequent insulin secretory decline.
Hideyuki Okuma   +4 more
wiley   +1 more source

Circulating TGF‐β1 Increases During Vaginal Progesterone Therapy in Women With a Short Cervix

open access: yesScandinavian Journal of Immunology, Volume 104, Issue 5, November 2026.
Progesterone treatment was associated with increased plasma TGF‐β1 concentrations in pregnant women at risk of spontaneous preterm birth. These findings suggest that progesterone may enhance immunoregulatory pathways relevant to pregnancy maintenance, although the underlying mechanism remains to be established.
Zdeněk Laštůvka   +7 more
wiley   +1 more source

Clinical Approach to Latent Autoimmune Diabetes in Adults: State of the Art and Future Perspectives

open access: yesEndocrinology Research and Practice
Latent autoimmune diabetes in adults (LADA) is the most common form of type 1 diabetes (T1D) that appears in adulthood. Initially, its clinical presentation resembles type 2 diabetes (T2D).
İlhan Satman
doaj   +1 more source

A study of Latent Autoimmune Diabetes in Adults and ketosis prone type 2 diabetes mellitus

open access: yes, 2011
Latent Autoimmune Diabetes in Adults (LADA) is an ill-defined autoimmune disorder separated from typical type 1 diabetes (DM-1), because of features suggestive of type 2 diabetes (DM-2). To better understand LADA, we compared it with ketosis prone type 2
Djekic, Kristina
core  

Home - About - Disclaimer - Privacy